CENTENE CORP 8-K

What Happened
Centene Corporation (CNC) filed an 8-K reporting that, effective May 12, 2026, the Board confirmed its executive officer lineup and disclosed results from the company’s annual meeting. The Board named Daniel Finke Group President, Medicaid and Marketplace, and Michael Carson Group President, Medicare and Specialty. The company’s executive officers now include Sarah London (CEO), Drew Asher (CFO), Daniel Finke, Michael Carson, Susan Smith (COO), Christopher Koster (General Counsel), and Theodore Pienkos (Corporate Controller & Chief Accounting Officer). Tanya McNally remains Chief People Officer.

Key Details

• 412,968,059 shares of common stock were represented at the May 12, 2026 Annual Meeting.
• All nine director nominees were elected for one-year terms; vote tallies were reported for each nominee (examples: Jessica L. Blume — 321,886,427 For; Kenneth A. Burdick — 378,901,985 For).
• Non-binding advisory vote on executive compensation (say-on-pay) passed: 349,896,589 For, 31,993,126 Against, 671,244 Abstain.
• KPMG LLP was ratified as the independent registered public accounting firm for fiscal 2026: 390,477,647 For, 22,337,787 Against.
• Shareholder proposal to require an independent board chairman was rejected: 72,839,667 For, 308,562,931 Against, 1,158,361 Abstain.

Why It Matters
These disclosures clarify Centene’s leadership structure and show shareholder support levels on governance and pay matters. Confirmed executive appointments identify who will lead the company’s Medicaid, Marketplace, Medicare and Specialty businesses—important for investors tracking operational leadership. The passed say-on-pay vote and ratification of KPMG indicate broad investor backing for current compensation practices and the auditor, while the rejection of an independent-chair proposal signals shareholders favored maintaining the existing board leadership structure.